National Center for
Global Health and Medicine, Japan (NCGM)

About NCGM

NCGM is a national research and development institution operating under
the purview of Japan’s Ministry of Health, Labour and Welfare.It comprises
the Center for Clinical Sciences, the center Hospital (43 departmentsand 719 beds), Kohnodai Hospital (200 general beds and 135 psychiatricbeds), the Bureau of International Health Cooperation, Research Institutes,
and the National College of Nursing, Japan.
Established in 1871 as an annex to the Army Medical Corps and formallybecame the fourth National Center in Japan in 1993. NCGM spearheads
pioneering research and development in the field of infectious diseases
treatment.
In April 2025, the NCGM will merge with the National Institute ofInfectious Diseases to form the Japan Institute for Health Security (JIHS).
This merger aims to strengthen the institute’ s capacity to provide
comprehensive scientific evidence, from epidemiological investigation toclinical research, during the emergence and spread of infectious diseases.

NCGM and ARISE

1

National Center for
Global Health and Medicine, Japan (NCGM)

Department of International Trials (DIT)
Established in 2016, the DIT within the Center for Clinical Sciences, aims
to support the design and conduct of international clinical trials for bothindustry and academia. To pursue this aim, the NCGM launched the ARISE
network and DIT serves as its Secretariat.
It has supported several clinical trials of medicines, diagnostic devices,
pharmaceuticals, diagnostic equipment, and other medical interventions.
In 2023, in collaboration with the National University of Colombia, DIT
conducted a clinical trial for a smallpox vaccine against mpox in Colombia.
Primary focus areas are infectious diseases.

Koji Wada
MD MSc PhD Prof (Hiroshima),
Director of DIT General Secretary of the ARISE
Dr. Wada has an extensive background in healthcare,research, and academia. He was Senior Director formedical affairs at a global pharmaceutical company.
Professor in the Department of Public Health at theFaculty of Medicine, International University of Healthand Welfare.

Muchanga Sifa Marie Joelle
MD. PhD, DIT’s International Liaison
ARISE Secretariat Contact Person
Dr. Sifa is a certified Clinical Research Coordinator withmore than 5 years experience at NCGM as a ProjectManager liaising with researchers from Japan andoverseas.
“We are committed to implementing a sustainable
and resilient clinical trials platform, ready to respondin a timely manner to the emergence of a global
infectious threat and to provide solutions to patients’needs. We value your partnership.”

2NCGM and ARISE

ARISE: An International Trials Network towards
Pandemic Preparedness and infectious diseases

About ARISE
The ARO Alliance for Southeast & East Asia (ARISE) is a network ofacademic research organizations (AROs) in Southeast and East Asian
countries dedicated to fostering collaboration and facilitating the clinical
trials of therapeutics, vaccines, and diagnostics for infectious diseases thathas benefits to human health.
Asia is recognized as the epicenter of emerging and re-emerging infectious
diseases. However, the majority of Asian countries lack the human andinfrastructural capacity to conduct trials of essential medical products forpandemic preparedness. There is an urgent need for a robust and resilient
cross-border medical product development system for infectious diseases.
NCGM established the ARISE with funding from the AMED (Japan Agencyfor Medical Research and Development) in 2021. This is an international
network of AROs dedicated to building pandemic preparedness in Asia,
mainly in Southeast Asia, by developing an epidemic-ready clinical trial
operations platform. ARISE plays a key role in promoting global pandemic
preparedness through international collaboration with other clinical trial
networks.

Goals of ARISE (2024-2025)■ Promote participation in and conduct of clinical trials incollaboration with industries■ Ensure the integrity, safety, ethics, and quality of investigatorinitiated clinical trials■ Enhance the resources and capacity for clinical trial
implementation

NCGM and ARISE

3

ARISE: An International Trials Network towards
Pandemic Preparedness and infectious diseases

ARISE Network■

1089614743
2

513

1
1211Japan① National Center for Global Health andMedicine② Nagasaki University③ Kyushu University④ International University of Health and Welfare⑤ Osaka University■

Indonesia⑥ Faculty of Medicine, University of Indonesia⑦ Mochtar Riady Institute for Nanotechnology■Malaysia⑧ Clinical Research Malaysia⑨ University of Malaya Medical Center■

Thailand⑩ Faculty of Medicine, Siriraj Hospital,Mahidol University■

The Philippines⑪ Corazon Locsin Montelibano Memorial
Regional Hospital⑫ University of the Philippines Manila⑬ West Visayas State University■

Vietnam⑭ Bach Mai Hospital

Contact Us

4NCGM and ARISE

ARISE SECRETARIAT OFFICE
Department of International Trials (DIT)
Center for Clinical Sciences
National Center for Global Health and Medicine
1-21-1, Toyama, Shinjuku, Tokyo 162-8655 JAPANe-mail: arise@hosp.ncgm.go.jp